InnoCare Pharma Grants 1.4 Million RSUs Under 2023 Share Award Scheme
I'm PortAI, I can summarize articles.
InnoCare Pharma Limited has granted 1.4 million Restricted Share Units (RSUs) to two grantees under its 2023 Share Award Scheme, with a grant date of December 31, 2025. The vesting of these RSUs may depend on performance targets related to company and individual metrics, including operating revenue and clinical trial numbers. A clawback mechanism is also included under certain conditions. This announcement was published via the Hong Kong Stock Exchange.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments